Jennifer J. Harris

The Janus Kinase 2 Inhibitor Fedratinib Inhibits Thiamine Uptake: A Putative Mechanism for the Onset of Wernicke’s Encephalopathy

Qiang Zhang, Yan Zhang, Sharon Diamond et al. · Drug Metabolism and Disposition · 2014 · 121 citations

Medicine, Pharmacology, Pharmacotherapy +14

Pharmacokinetic Properties and Human Use Characteristics of an FDA‐Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose

Philip A. Krieter, Nora Chiang, Shwe Gyaw et al. · The Journal of Clinical Pharmacology · 2016 · 109 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Pharmacokinetics/pharmacodynamics of a β-lactam and β-lactamase inhibitor combination: a novel approach for aztreonam/avibactam

Renu Singh, Aryun Kim, M. Angela Tanudra et al. · Journal of Antimicrobial Chemotherapy · 2015 · 95 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Relative Contributions of Cytochrome CYP3A4 Versus CYP3A5 for CYP3A-Cleared Drugs Assessed In Vitro Using a CYP3A4-Selective Inactivator (CYP3cide)

Elaine Tseng, Robert L. Walsky, Ricardo A. Luzietti et al. · Drug Metabolism and Disposition · 2014 · 94 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Substrate- and Species-dependent Inhibition of P-glycoprotein-mediated Transport: Implications for Predicting in vivo Drug Interactions

Joseph K. Zolnerciks, Catherine Booth-Genthe, Anshul Gupta et al. · Journal of Pharmaceutical Sciences · 2011 · 53 citations

Medicine, Pharmacokinetics, Pharmacology +16